BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32341035)

  • 1. Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
    Zhou H; Blevins MA; Hsu JY; Kong D; Galbraith MD; Goodspeed A; Culp-Hill R; Oliphant MUJ; Ramirez D; Zhang L; Trinidad-Pineiro J; Mathews Griner L; King R; Barnaeva E; Hu X; Southall NT; Ferrer M; Gustafson DL; Regan DP; D'Alessandro A; Costello JC; Patnaik S; Marugan J; Zhao R; Ford HL
    Cancer Res; 2020 Jun; 80(12):2689-2702. PubMed ID: 32341035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
    Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
    Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.
    Liang Y; Xu X; Wang T; Li Y; You W; Fu J; Liu Y; Jin S; Ji Q; Zhao W; Song Q; Li L; Hong T; Huang J; Lyu Z; Ye Q
    Cell Death Dis; 2017 Jul; 8(7):e2928. PubMed ID: 28703807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
    Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
    Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.
    Kingsbury TJ; Kim M; Civin CI
    Adv Cancer Res; 2019; 141():1-42. PubMed ID: 30691681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function analyses of the human SIX1-EYA2 complex reveal insights into metastasis and BOR syndrome.
    Patrick AN; Cabrera JH; Smith AL; Chen XS; Ford HL; Zhao R
    Nat Struct Mol Biol; 2013 Apr; 20(4):447-53. PubMed ID: 23435380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
    Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SIX1, EYA2, and E-cadherin in ovarian carcinoma. Evidence on epithelial-mesenchymal transition from an immunohistochemical study.
    Dawoud MM; Aiad HAES; Tawfiq EAE; Al-Qalashy FSA; Eissa N; El-Rebey HS
    Ann Diagn Pathol; 2021 Dec; 55():151815. PubMed ID: 34534789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.
    Krueger AB; Dehdashti SJ; Southall N; Marugan JJ; Ferrer M; Li X; Ford HL; Zheng W; Zhao R
    J Biomol Screen; 2013 Jan; 18(1):85-96. PubMed ID: 22820394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.
    Vincent A; Hong SM; Hu C; Omura N; Young A; Kim H; Yu J; Knight S; Ayars M; Griffith M; Van Seuningen I; Maitra A; Goggins M
    Oncotarget; 2014 May; 5(9):2575-87. PubMed ID: 24810906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.
    Krueger AB; Drasin DJ; Lea WA; Patrick AN; Patnaik S; Backos DS; Matheson CJ; Hu X; Barnaeva E; Holliday MJ; Blevins MA; Robin TP; Eisenmesser EZ; Ferrer M; Simeonov A; Southall N; Reigan P; Marugan J; Ford HL; Zhao R
    J Biol Chem; 2014 Jun; 289(23):16349-61. PubMed ID: 24755226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk.
    Kong D; Zhou H; Neelakantan D; Hughes CJ; Hsu JY; Srinivasan RR; Lewis MT; Ford HL
    Oncogene; 2021 Feb; 40(5):964-979. PubMed ID: 33299122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.
    Heanue TA; Reshef R; Davis RJ; Mardon G; Oliver G; Tomarev S; Lassar AB; Tabin CJ
    Genes Dev; 1999 Dec; 13(24):3231-43. PubMed ID: 10617572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
    Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
    J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two naturally derived small molecules disrupt the sineoculis homeobox homolog 1-eyes absent homolog 1 (SIX1-EYA1) interaction to inhibit colorectal cancer cell growth.
    Wu J; Huang B; He HB; Lu WZ; Wang WG; Liu H
    Chin Med J (Engl); 2021 Sep; 134(19):2340-2352. PubMed ID: 34561318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.
    Anantharajan J; Zhou H; Zhang L; Hotz T; Vincent MY; Blevins MA; Jansson AE; Kuan JWL; Ng EY; Yeo YK; Baburajendran N; Lin G; Hung AW; Joy J; Patnaik S; Marugan J; Rudra P; Ghosh D; Hill J; Keller TH; Zhao R; Ford HL; Kang C
    Mol Cancer Ther; 2019 Sep; 18(9):1484-1496. PubMed ID: 31285279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma.
    Yang ZC; Qu ZH; Yi MJ; Shan YC; Ran N; Xu L; Liu XJ
    J Cell Physiol; 2019 Jun; 234(6):8804-8814. PubMed ID: 30362537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
    Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.